Finance

Rivian electric pickup trucks sit in a parking lot at a Rivian service center on May 09, 2022 in South San Francisco, California. 
Justin Sullivan | Getty Images

Check out the companies making headlines after hours.

Rivian — Shares of the electric vehicle maker increased 2.7% after announcing after the bell that production met expectations in its quarter ending Sept. 30.

Dynatrace — The software intelligence company jumped 4.6% after being upgraded to a buy from JPMorgan. Earlier, the stock rose 3% during regular trading.

Kezar Life Sciences — Shares of the biotechnology company were up 2.3% after it announced FDA clearance of its investigational new drug application for an autoimmune hepatitis treatment.

Rocket Pharmaceuticals — The stock dropped 4.6% after the company started a $100 million secondary. Underwriters have a 30-day option to purchase up to $15 million in additional shares.

Articles You May Like

‘If Americans want lower interest rates, they’re going to have to do it themselves,’ analyst says. Here’s how
Carvana Surges 40% After Earnings Beat
China’s automakers must adapt quickly or lose out on the EV boom in the face of regulatory scrutiny abroad and competition at home
Demand for riskier adjustable-rate mortgages hits highest level of the year, due to rising rates
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold